Biotechnology News

April 7, 2014

NEW YORK--(BUSINESS WIRE)--Deerfield Management Company announced today that it has launched Deerfield Private Design Fund III, an investment fund designed to provide flexible private financing to healthcare companies. The fund has approximately...

April 7, 2014

PARSIPPANY, N.J.--(BUSINESS WIRE)--Pacira Pharmaceuticals Announces Proposed Public Offering of Common Stock

April 7, 2014

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River announces the date of its first-quarter 2014 earnings release and conference call. The conference call will be held on May 1, 2014 at 9:00am EDT.

April 7, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today presented new preclinical data demonstrating the ability of its Toll-like receptor (TLR) antagonist, IMO-8400, to inhibit the survival and proliferation of B-cell...

April 7, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND presents clinical data demonstrating differentiating attributes of BIND-014 administered with a weekly dosing schedule which may enable increased dose intensity and enhanced therapeutic efficacy

April 7, 2014

CINCINNATI--(BUSINESS WIRE)--Aerpio Therapeutics' President and CEO, Joseph Gardner, PhD, will present at the 13th Annual Needham Healthcare Conference on Wednesday, April 9, 2014, at 9:20 am ET.

April 7, 2014

TEL AVIV, Israel--(BUSINESS WIRE)--StoreDot demos new battery technology that will allow you to charge your smartphone in 30 seconds.

April 7, 2014

WASHINGTON--(BUSINESS WIRE)--Optegra, the specialist eye hospital group, announces today that it is further investing in the advanced LENSAR(TM) Femtosecond Cataract Laser distributed by Topcon. Optegra will become the first national eye care...

April 7, 2014

BOSTON--(BUSINESS WIRE)--MDGBoston announced today that it will sponsor a symposium on Wednesday, June 11, 2014: “The Year of the Brain: Advances in Imaging, Diagnostics and Therapeutic Delivery,” from 3:30—8:00 p.m. at Foley Hoag Law Offices,...

April 7, 2014

LOS ANGELES--(BUSINESS WIRE)--Positive data from Puma Biotechnology's Phase II I-SPY 2 TRIAL of PB272 for the neoadjuvant treatment of breast cancer was presented at the AACR 2014 Annual Meeting.

April 7, 2014

ST. PAUL, Minn.--(BUSINESS WIRE)--Saint Paul-based gene-editing innovator Surrogen announced its entry into the marketplace, further advancing a leadership position in biomedicine and replicable human disease models. The announcement is being...

April 7, 2014

GAITHERSBURG, Md.--(BUSINESS WIRE)--Smithers Avanza announced that Dr. Michael Dorato has been appointed as Executive Vice President, Smithers Avanza Development Services.

April 7, 2014

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) today highlighted research related to its antibody-drug conjugate (ADC) programs and technology in more than 15 presentations at the 105th Annual Meeting of the American...

April 7, 2014

MUNICH--(BUSINESS WIRE)--Definiens announced today that it has signed an agreement with INSERM Transfert to sponsor the worldwide consortium for the validation of the Immunoscore, a new approach to cancer therapy.

April 7, 2014

WASHINGTON--(BUSINESS WIRE)--Executives from consumer product and renewable chemical companies will present recent achievements in synthetic biology and genomics research at the BIO World Congress on Industrial Biotechnology.

April 7, 2014

TORONTO--(BUSINESS WIRE)--The second Canadian Live Below the Line campaign, presented by the Micronutrient Initiative, kicks off in three weeks. From April 28 to May 2, 2014, participants will spend only $1.75 per day on all food and drink, the...

April 7, 2014

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (NASDAQ: CGEN) issued the following statement today. In recent days newspapers in Israel have reported that the Israel Securities Authority (“ISA”) is investigating Mr. Aryeh Czaczkes Axselbrad,...

April 7, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--PatientsLikeMe announces a 5-year agreement with Genentech to explore use of PatientsLikeMe’s network to develop innovative ways of researching patients’ real-world experiences.

April 7, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea appoints Jonathan Poole to the position of chief financial officer.

April 7, 2014

EAGAN, Minn.--(BUSINESS WIRE)--Research further elucidating the role of the biomarker for Biothera’s cancer immunotherapy Imprime PGG® will be presented today at the American Association for Cancer Research’s (AACR) annual meeting in San Diego....

April 7, 2014

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Announces Once-Daily Aptiom® (eslicarbazepine acetate) for the Adjunctive Treatment of Partial-Onset Seizures Now Available in U.S. Pharmacies

April 7, 2014

SAN FRANCISCO--(BUSINESS WIRE)--McKesson Corporation (NYSE:MCK), a leading North American healthcare services and information technology company, announced today that the results of the initial acceptance period of the voluntary public takeover...

April 7, 2014

SUNNYVALE, Calif.--(BUSINESS WIRE)--"Icon is on the threshold of an important new growth phase and I expect Icon's Verisome technology to drive a transformational change in ophthalmic pharmaceuticals," said David S. Tierney

April 7, 2014

SAN DIEGO--(BUSINESS WIRE)--Knowledge of driver mutations is essential to research and development in the pharmaceutical industry for the identification of novel populations and discovery of new cancer drug targets. Gene over-expression is one of...

April 7, 2014

SALT LAKE CITY--(BUSINESS WIRE)--Tolero Pharmaceuticals, Inc., a clinical-stage company developing treatments for serious hematological diseases, today announced that a poster related to its development program alvocidib, a potent cyclin-...

April 7, 2014

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ: CERS) announced today that it has submitted its Medical Device license application to Health Canada for review of the INTERCEPT Blood system for plasma. This follows an agreement...

April 7, 2014

NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ), a vertically integrated biosciences and clinical laboratory company, announced today that Barry Weiner, President, will be presenting at the 13th Annual Needham Healthcare Conference at 4:...

April 7, 2014

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted priority review to the company’s New Drug Application (NDA) for a once-daily fixed-dose...

April 7, 2014

SAN DIEGO--(BUSINESS WIRE)--A new high-content screening software platform enables cancer researchers to uncover more about basic and advanced cellular function to accelerate cell-based research. The Thermo Scientific HCS Studio 2.0 is a high-...

April 7, 2014

MENLO PARK, Calif.--(BUSINESS WIRE)--CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced results of a pooled analysis study of the first-of-its-kind catheter-based Parachute®...

April 7, 2014

BILLERICA, Mass. & SAN DIEGO--(BUSINESS WIRE)--Top cancer researchers showcase RainDance ThunderBolts™ Next-Gen Sequencing Cancer Panel and RainDrop™ Digital PCR System performance data at AACR Annual Meeting

April 7, 2014

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that they have submitted new drug applications (NDAs) with the U.S. Food and Drug Administration (FDA) for the investigational products daclatasvir (DCV),...

April 7, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), a leading RNAi therapeutics company, announced today that the European Patent Office (EPO) has upheld the McSwiggen EP 1423406 (’406) patent in oral opposition...

April 7, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mersana Therapeutics Enters Collaboration with Takeda to Develop Next-Generation Antibody-Drug Conjugates

April 7, 2014

TORONTO--(BUSINESS WIRE)--ANTIBE THERAPEUTICS COMPLETES SECOND CLOSING OF NON-BROKERED PRIVATE PLACEMENT BRINGING TOTAL PROCEEDS TO $3,925,358

April 7, 2014

SEATTLE & SAN DIEGO--(BUSINESS WIRE)--NanoString Introduces Novel PanCancer Gene Expression Panel for Multiplexed Pathway Analysis; PanCancer Pathways Panel Streamlines the Study of All Major Cancer Pathways and Associated Driver Genes

April 7, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Announces Presentations at the 2014 Annual Meeting of the American Association of Cancer Research

April 7, 2014

NEW YORK--(BUSINESS WIRE)--Actinium Pharmaceuticals has started a collaboration with IsoTherapeutics Group of Houston to complete studies required for introduction of a new manufacturing process for Actimab-A.

April 7, 2014

SAN DIEGO--(BUSINESS WIRE)--OncoSec Medical To Relaunch Phase 2 Cutaneous T-Cell Lymphoma Study at Key Centers of Excellence

April 7, 2014

DAVIS, Calif.--(BUSINESS WIRE)--BioConsortia Financing Release

April 7, 2014

LAWRENCE, Kan.--(BUSINESS WIRE)--Deciphera initiates Phase 1 clinical trial of its pan-RAF inhibitor LY3009120 (DP-4978), under development in collaboration with Eli Lilly. Data with preclinical activity presented at AACR.

April 7, 2014

LAWRENCE, Kan.--(BUSINESS WIRE)--Michael D. Taylor, Ph.D., appointed President and Chief Executive Officer of Deciphera as company is making clinical progress with its kinase inhibitor product candidates for several types of cancers